Kendra, Kari
The Ohio State University Wexner Medical Center
6 papers on CoChatORCID 0000-0001-5936-6689
Most cited papers
- Verified
Neoadjuvant-adjuvant or adjuvant-only pembrolizumab in advanced melanoma
Patel, S. P., Othus, M., Chen, Y., Wright, G. P., Yost, K. J., Hyngstrom, J. R., Hu-Lieskovan, S., Lao, C. D., Fecher, L. A., Truong, T.-G., et al. (2023) · New England Journal of Medicine
Cutaneous Melanoma Detection and ManagementCancer Immunotherapy and Biomarkers
Cited by 919
- Verified
Nitric Oxide Production by Myeloid Derived Suppressor Cells Plays a Role in Impairing Fc Receptor-Mediated Natural Killer Cell Function.
Stiff, A., Trikha, P., Mundy-Bosse, B., McMichael, E., Mace, T. A., Benner, B., Kendra, K., Campbell, A., Gautam, S., Abood, D., et al. (2018) · Clinical Cancer Research
Immune cells in cancerImmune Cell Function and Interaction
Cited by 244
- Verified
Myeloid-derived suppressor cells express Bruton's tyrosine kinase and can be depleted in tumor-bearing hosts by ibrutinib treatment
Stiff, A., Trikha, P., Wesolowski, R., Kendra, K., Hsu, V., Uppati, S., McMichael, E., Duggan, M., Campbell, A., Keller, K., et al. (2016) · Cancer Research
Immune cells in cancerImmunotherapy and Immune Responses
Cited by 188
- Verified
Phase III study of adjuvant ipilimumab (3 or 10 mg/kg) versus high-dose interferon alfa-2b for resected high-risk melanoma: North American Intergroup E1609
Tarhini, A. A., Lee, S. J., Hodi, F. S., Rao, U. N. M., Cohen, G. I., Hamid, O., Hutchins, L. F., Sosman, J. A., Kluger, H. M., Eroglu, Z., et al. (2020) · Journal of Clinical Oncology
Cutaneous Melanoma Detection and ManagementCancer Immunotherapy and Biomarkers
Cited by 184
- Verified
Gene Expression Profiling Reveals Similarities between the In vitro and In vivo Responses of Immune Effector Cells to IFN-α
Zimmerer, J. M., Lesinski, G. B., Ruppert, A. S., Radmacher, M. D., Noble, C., Kendra, K., Walker, M. J., & Carson, W. E. (2008) · Clinical Cancer Research
interferon and immune responsesImmunotherapy and Immune Responses
Cited by 33
- Verified
Comparative assessment of manual chart review and ICD claims data in evaluating immunotherapy-related adverse events
Nashed, A., Zhang, S., Chiang, C.-W., Zitu, M., Otterson, G. A., Presley, C. J., Kendra, K., Patel, S. H., Johns, A., Li, M., et al. (2021) · Cancer Immunology, Immunotherapy
Cancer Immunotherapy and BiomarkersMedical Coding and Health Information
Cited by 22
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free